Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095251
Status:
COMPLETED
Last Update Posted:
2018-09-11
First Post:
2004-11-01
Brief Title:
MENDS Study Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid GABA-Agonist to Determine Delirium Rates Efficacy of Sedation Analgesia and Discharge Cognitive Status
Sponsor:
Vanderbilt University
Organization:
Vanderbilt University Medical Center
Study Overview
Official Title:
A Randomized Double-blind Trial in Ventilated ICU Patients Comparing Treatment With an Alpha2 Agonist Versus a Gamma Aminobutyric Acid GABA-Agonist to Determine Delirium Rates Efficacy of Sedation Analgesia and Discharge Cognitive Status
Status:
COMPLETED
Status Verified Date:
2018-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Delirium has recently been shown as a predictor of death increased cost and longer length of stay in ventilated patients Sedative and analgesic medications relieve anxiety and pain but may contribute to patients transitioning into delirium It is possible that modifying the paradigm for sedation using novel therapies targeted at different receptors such as dexmedetomidine targeting alpha2 receptors and sparing the GABA receptors could provide efficacious sedation yet reduce the development duration and severity of acute brain dysfunction delirium
Detailed Description:
Delirium occurs in 60-80 of ventilated Intensive Care Unit ICU patients and is independently associated with prolonged hospital stay higher cost a 3-fold increased risk of dying by six months and ongoing neuropsychological dysfunction Hypothesis Based on our preliminary work we hypothesize that standard use of GABA agonist sedatives such as lorazepam and propofol may contribute to ICU delirium and its attendant untoward clinical outcomes An alternative sedation strategy targeting alpha2 receptors and sparing GABA receptors dexmedetomidine might reduce delirium provide adequate sedation reduce analgesic requirement and concurrently improve cognitive performance
Long-term objective To standardize and compare different strategies of sedation and analgesia for ventilated ICU patients in order to optimize their clinical outcomes focusing on delirium and the long-term neuropsychological dysfunction of ICU survivors
Specific Aims
to study prevalence and duration of delirium in critically ill patients using differential exposure to alpha2 vs GABA receptor agonists while evaluating efficacy of sedation and analgesia
to compare clinical outcomes including duration of mechanical ventilation ICU length of stay and severity of neuropsychological dysfunction at hospital discharge and
to develop pharmacokinetic and pharmacodynamic models for dexmedetomidine and lorazepam when used for up to 5 days in ICU patients
Relationship to anesthesiology We will study whether the adverse clinical outcomes associated with ICU delirium including long-term neuropsychological dysfunction can be modified by the choice of psychoactive agents frequently used by anesthesiologists and intensivists
Design A blinded randomized controlled trial of adult mechanically ventilated patients using a sedation strategy of dexmedetomidine fentanyl versus lorazepam fentanyl with relevant outcomes and safety monitoring
Long-term objective To standardize and compare different strategies of sedation and analgesia for ventilated ICU patients in order to optimize their clinical outcomes focusing on delirium and the long-term neuropsychological dysfunction of ICU survivors
Specific Aims
to study prevalence and duration of delirium in critically ill patients using differential exposure to alpha2 vs GABA receptor agonists while evaluating efficacy of sedation and analgesia
to compare clinical outcomes including duration of mechanical ventilation ICU length of stay and severity of neuropsychological dysfunction at hospital discharge and
to develop pharmacokinetic and pharmacodynamic models for dexmedetomidine and lorazepam when used for up to 5 days in ICU patients
Relationship to anesthesiology We will study whether the adverse clinical outcomes associated with ICU delirium including long-term neuropsychological dysfunction can be modified by the choice of psychoactive agents frequently used by anesthesiologists and intensivists
Design A blinded randomized controlled trial of adult mechanically ventilated patients using a sedation strategy of dexmedetomidine fentanyl versus lorazepam fentanyl with relevant outcomes and safety monitoring
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None